Artificial Intelligence

Shareholders mad at Meta over strategy: The tech giant launches AI tools to help build the metaverse. It’s a long-game strategy that irks investors with little to show after a $15B expenditure.

Big Tech’s one-track mind: Google and Microsoft may be slashing expenses, but they’re not holding back when it comes to AI. Cloud providers and GPU makers could be the winners.

TikTok pushes an AI advertising product: The app’s strong position is letting it experiment with machine learning to court advertisers big and small.

Bank of America’s Erica reached 1B customer interactions, helped by offering both human and digital assistance.

Generative AI’s trillion-dollar wellspring: Tech shows its love for the arts as long as AI’s the artist. It’s an economic bright spot, but brace for ethical and legal controversy.

Google goes ambient: New Pixel phones, the first ever Pixel smartwatch, and a future tablet that transforms into a smart display are all touchpoints to Google’s wider IoT and ambient computing aspirations.

Supply chains snafus are easing, but retailers aren’t out of the woods yet: More investment in supply chain management and automation is needed to futureproof operations as climate change disrupts logistics networks.

A new survey on dental patient trust indicates that could be true, and AI implementation may help dentists earn their patients trust.

Sparrow AI chatbot isn’t ready for public consumption: DeepMind researchers want to ensure the new chatbot is safe before release. Their approach could help make conversational AI products more useful.

Nvidia’s new edge AI computing platform highlights the need to protect surgical robots and medical devices from hacking.

Augment promises ‘the future of productivity’ is here: After a year of secrecy, the startup is now beta testing a potentially disruptive virtual assistant. Watch for mimicry and takeover attempts.

Pfizer expands its agreement with CytoReason by five years to boost AI’s role in drug development. We spotlight the trend in the pharma world.

Researchers splash cold water on AI progress: A new study paints a grim scenario of how AI could turn on humanity. It illustrates the benefits of tech companies heeding ethicists' warnings.

EU moves to make IoT devices safer: Smart home device manufacturers are being compelled to develop more secure devices and be more transparent about flaws and fixes. Industry-wide standards are needed.

Voice assistants are progressively becoming embedded in daily life as the technologies behind these products improve. Tech companies are increasingly centralizing their product strategies around voice assistants by incorporating them into more products to build out their respective ecosystems.

pharma companies like Novo Nordisk are using AI to cull data insights for drug discovery.

Reddit’s AI acquisition will help with targeting, brand safety: The platform says Spiketrap will help contextualize conversations and advertising on its platform.

Virtual Incision’s plans for a robotic space visit highlight the need to make digital surgery devices much smaller.

Google’s ‘sentient’ chatbot unleashed: LaMBDA 2 will soon be available for public testing. With the precautionary principle ignored, it’s the latest experimental chatbot trained via the internet and random conversations.